Cargando…
Co-Therapy of Albendazole and Dexamethasone Reduces Pathological Changes in the Cerebral Parenchyma of Th-1 and Th-2 Dominant Mice Heavily Infected with Angiostrongylus cantonensis: Histopathological and RNA-seq Analyses
Administration of albendazole alone was not very suitable for the treatment of cerebral angiostrongyliasis. This study was designed to evaluate the effects of the co-therapy of this drug and dexamethasone in Th-1 and Th-2 dominant mice infected with Angiostrongylus cantonensis. Each of BALB/c and C5...
Autores principales: | Jhan, Kai-Yuan, Cheng, Chien-Ju, Jung, Shih-Ming, Lai, Yi-Jen, Chen, Kuang-Yao, Wang, Lian-Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067505/ https://www.ncbi.nlm.nih.gov/pubmed/33917604 http://dx.doi.org/10.3390/biom11040536 |
Ejemplares similares
-
Angiostrongylus cantonensis causes cognitive impairments in heavily infected BALB/c and C57BL/6 mice
por: Jhan, Kai-Yuan, et al.
Publicado: (2020) -
Albendazole-Schisandrin B Co-Therapy on Angiostrongylus cantonensis-Induced Meningoencephalitis in Mice
por: Lam, Ho Yin Pekkle, et al.
Publicado: (2020) -
Proteomic analysis of excretory-secretory products from young adults
of Angiostrongylus cantonensis
por: Chen, Kuang-Yao, et al.
Publicado: (2019) -
Synaptic loss and progression in mice infected with Angiostrongylus cantonensis in the early stage
por: Jhan, Kai-Yuan, et al.
Publicado: (2022) -
Human Angiostrongylus cantonensis, Jamaica
por: Waugh, Cecelia A., et al.
Publicado: (2005)